306 related articles for article (PubMed ID: 16425970)
1. Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union.
Wonnemann M; Schug B; Schmücker K; Brendel E; van Zwieten PA; Blume H
Int J Clin Pharmacol Ther; 2006 Jan; 44(1):38-48. PubMed ID: 16425970
[TBL] [Abstract][Full Text] [Related]
2. The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast.
Schug BS; Brendel E; Chantraine E; Wolf D; Martin W; Schall R; Blume HH
Br J Clin Pharmacol; 2002 Jun; 53(6):582-8. PubMed ID: 12047482
[TBL] [Abstract][Full Text] [Related]
3. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
Anschütz M; Wonnemann M; Schug B; Toal C; Donath F; Pontius A; Pauli K; Brendel E; Blume H
Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
[TBL] [Abstract][Full Text] [Related]
5. Dosage form-related food interaction observed in a marketed once-daily nifedipine formulation after a high-fat American breakfast.
Schug BS; Brendel E; Wonnemann M; Wolf D; Wargenau M; Dingler A; Blume HH
Eur J Clin Pharmacol; 2002 May; 58(2):119-25. PubMed ID: 12012144
[TBL] [Abstract][Full Text] [Related]
6. Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union.
Schug BS; Brendel E; Wolf D; Wonnemann M; Wargenau M; Blume HH
Eur J Pharm Sci; 2002 Apr; 15(3):279-85. PubMed ID: 11923060
[TBL] [Abstract][Full Text] [Related]
7. [Role of food interaction pharmacokinetic studies in drug development. Food interaction studies of theophylline and nifedipine retard and buspirone tablets].
Drabant S; Klebovich I; Gachályi B; Renczes G; Farsang C
Acta Pharm Hung; 1998 Sep; 68(5):294-306. PubMed ID: 9805816
[TBL] [Abstract][Full Text] [Related]
8. The influence of two types of meal on the pharmacokinetics of a modified-release formulation of nifedipine (Adalat Retard).
Armstrong J; Challenor VF; Macklin BS; Renwick AG; Waller DG
Eur J Clin Pharmacol; 1997; 53(2):141-3. PubMed ID: 9403286
[TBL] [Abstract][Full Text] [Related]
9. Comparative Bioequivalence and Food Effect of Two Formulations of 30-mg Nifedipine Controlled-Release Tablets in Healthy Chinese Adults.
Zhang H; Wang S; Wang H; Zhi T; Ren J; Wang Y; Yao Z; Zhang P; Ye N; Zhang R
Clin Pharmacol Drug Dev; 2024 May; 13(5):499-505. PubMed ID: 38478175
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
11. Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration.
Dulac O; Alvarez JC
Pharmacotherapy; 2005 Jan; 25(1):35-41. PubMed ID: 15767218
[TBL] [Abstract][Full Text] [Related]
12. Relative bioavailability of four controlled-release nifedipine products.
Schall R; Müller FO; Hundt HK; Duursema L; Groenewoud G; Van Dyk M; Van Schalkwyk AM
Biopharm Drug Dispos; 1994 Aug; 15(6):493-503. PubMed ID: 7993987
[TBL] [Abstract][Full Text] [Related]
13. Food interaction pharmacokinetic study of cordaflex 20 mg retard filmtablet in healthy volunteers.
Balogh Nemes K; Horváth V; Grézal G; Horvai G; Hrabéczy-Páll A; Kocsi E; Drabant S; Csörgö M; Renczes G; Klebovich I
Int J Clin Pharmacol Ther; 1998 May; 36(5):263-9. PubMed ID: 9629990
[TBL] [Abstract][Full Text] [Related]
14. Relative bioavailability study of two nifedipine tablet formulations in healthy male volunteers.
Niopas I; Daftsios AC; Xanthakis I; Nikolaidis N
Int J Clin Pharmacol Ther; 2000 Jun; 38(6):309-14. PubMed ID: 10890580
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and Bioequivalence of 2 Nifedipine Controlled-Release Tablets: A Randomized, Single-Dose, 2-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Xin L; Chen Q; Chen D; Li Y; Li Y; Wu Q; Zou Y; Wang W; Jia J; Yu C; Liu Y
Clin Pharmacol Drug Dev; 2023 Nov; 12(11):1082-1088. PubMed ID: 37132398
[TBL] [Abstract][Full Text] [Related]
16. SLI381 (Adderall XR), a two-component, extended-release formulation of mixed amphetamine salts: bioavailability of three test formulations and comparison of fasted, fed, and sprinkled administration.
Tulloch SJ; Zhang Y; McLean A; Wolf KN
Pharmacotherapy; 2002 Nov; 22(11):1405-15. PubMed ID: 12432966
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and Tolerability Comparison of Sustained and Immediate Release Oral Formulations of Nifedipine Tablet Formulations: A Single-Dose, Randomized, Open-Label, Two-Period, Two-Way Crossover Study in Healthy, Fasting Egyptian Male Volunteers.
El-Masry SM; El-Khodary NM
Drug Res (Stuttg); 2020 Feb; 70(2-03):91-96. PubMed ID: 31746448
[TBL] [Abstract][Full Text] [Related]
18. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
19. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.
Grundy JS; Foster RT
Clin Pharmacokinet; 1996 Jan; 30(1):28-51. PubMed ID: 8846626
[TBL] [Abstract][Full Text] [Related]
20. Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials.
Devarakonda K; Kostenbader K; Giuliani MJ; Young JL
BMC Pharmacol Toxicol; 2015 Nov; 16():31. PubMed ID: 26614499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
